| Haloperidol | |||||||||||||||||
| Type | Antipsychotic | ||||||||||||||||
| Group | Butyrophenones | ||||||||||||||||
| links | |||||||||||||||||
| ATC-code | N05AD01 | ||||||||||||||||
| Medscape | Haloperidol | ||||||||||||||||
| PubChem | 3559 | ||||||||||||||||
| PubMed | Haloperidol | ||||||||||||||||
| Drugs.com | haloperidol | ||||||||||||||||
| Kompas (Dutch) | Haloperidol | ||||||||||||||||
| Wikipedia | Haloperidol | ||||||||||||||||
| |||||||||||||||||
Haloperidol is a Antipsychotic in the group Butyrophenones.
- ↑ WHO Collaborating Centre for Drug Statistics Methodology ATC=N05AD01
- ↑ 2.0 2.1 The Lundbeck Institute; Psychotropics; Terminal Plasma Half-lives
- ↑ 3.0 3.1 Farmacotherapeutisch Kompas; Inleidende Tekst Antipsychotica (dutch)
- ↑ KNMP; Informatorium Medicamentorum 2023; Monografie "haloperidol" (Dutch)
| Haloperidol long acting | |||
| Type | Antipsychotic | ||
| Group | Butyrophenones | ||
| links | |||
| Medscape | Haloperidol | ||
| PubChem | 3559 | ||
| PubMed | Haloperidol | ||
| Kompas (Dutch) | Haloperidol | ||
| Wikipedia | Haloperidol | ||
| |||
Haloperidol (long acting) is a Antipsychotic in the group Butyrophenones.